The treatment of hyaluronic acid aesthetic interventional induced visual loss (AIIVL): A consensus on practical guidance.

Background: Visual loss (blindness) caused by injection of soft tissue fillers is a rare but devastating issue to both patient and practitioner. There is a lack of any structured protocol in the management of this problem AIMS: To produce a pathway for the management of hyaluronic acid aesthetic interventional induced visual loss that was based on the current available literature and guidelines. evidence proposed guidance for the practical management of this problem. was evaluated and a pathway has been developed for patient management and specialist advice METHOD: A consensus group experts involved in aesthetic intervention, visual loss research and with experience in dealing with visual loss assessed the current literature and proposed guidelines available. Using the protocols available a pathway for the treatment of aesthetic interventional induced visual loss was proposed.

Results: The group produce a set of guidelines for the practitioner to use as an emergency situation and for use in a delayed presentation. The group also produced guidelines for specialists to use in a secondary care setting.

Conclusions: These recommendations are based on current publications and or consensus view as there is still a lack of robust Level I data to support any particular intervention therapy.